Lukas Linnig News Today : Breaking News, Live Updates & Top Stories | Vimarsana

BRAIN Biotech AG: BRAIN Biotech AG s Akribion Genomics technology receives patent approval for its groundbreaking nuclease G-dase E® -September 14, 2023 at 04:32 am EDT

EQS-News: BRAIN Biotech AG / Key word: Patent BRAIN Biotech AG: BRAIN Biotech AG’s Akribion Genomics technology receives patent approval for its groundbreaking.

United statesUnited kingdomAdriaan moelkerMartina schusterStephanie konleLukas linnigMichael krohnDistribution servicesEuropean patent officeBiotech groupPr corporate communicationsStandard of the frankfurt stock exchangeAkribion genomicsIndustrial biotechnologyPrime standardFrankfurt stock exchange

EQS-News: BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition

EQS-News: BRAIN Biotech AG / Key word(s): Miscellaneous BRAIN Biotech AG´s Akribion Genomics team successfull.

United kingdomUnited statesMichael schneidersMartina schusterMichael krohnStephanie konleLukas linnigBiotech groupLife sciencesStandard of the frankfurt stock exchangePr corporate communicationsAkribion genomicsVenture cupIndustrial biotechnologyPrime standardFrankfurt stock exchange

BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition

EQS-News: BRAIN Biotech AG / Key word(s): Miscellaneous BRAIN Biotech AG´s Akribion Genomics team successfully competes in Science4Life Venture Cup competition 28.06.2023 / 13:00 CET/CEST The issuer is sol.

United statesUnited kingdomStephanie konleMartina schusterMichael krohnMichael schneidersLukas linnigPr corporate communicationsBiotech groupLife sciencesStandard of the frankfurt stock exchangeAkribion genomicsVenture cupAkribion genomicIndustrial biotechnologyPrime standard

TransCode Therapeutics and BRAIN Biotech join forces to develop a CRISPR-derived technology platform for cancer treatment

TransCode Therapeutics and BRAIN Biotech join forces to develop a CRISPR-derived technology platform for cancer treatment
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesLukas linnigMichael dudleyZdravka medarovaRelationsmartina schusterinvestor relationsphoneDirk sombroekTranscode contactalan freidmanExchange commissionTranscode therapeutics incStandard of the frankfurt stock exchangeCode therapeuticsAkribion genomicsUnited nations global compactPrime standardFrankfurt stock exchange

BRAIN Biotech AG: BRAIN Group s Akribion Genomics business will prioritize the development of therap

EQS-News: BRAIN Biotech AG / Key word(s): Strategic Company DecisionBRAIN Biotech AG: BRAIN Group's Akribion Genomics business will prioritize the development of therapeutic applications within its CRISPR technology platform 10.01.2023 / 12:15 CET/CESTThe issuer is solely responsible for the content of this anno.

United kingdomMichael krohnLukas linnigAdriaan moelkerMartina schusterStephanie konleStrategic company decisionPr corporate communicationsGroup akribion genomicsStandard of the frankfurt stock exchangeDistribution servicesAkribion genomicsContinental europeUnited nations global compactPrime standardFrankfurt stock exchange